Connealy Pamela Ann

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$229,930.14
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Connealy Pamela Ann

According to the SEC Form 4 filings, Connealy Pamela Ann, being in a position of

  1. CFO & COO at Pyxis Oncology, Inc.,
    оver the last 12 months, has bought 88850 shares for $174,364, and sold 0 shares,
    over all time since 2023-09-22, has bought 120276 shares for $229,930, and sold 0 shares.

The largest purchase of all time was on 2024-11-26 and amounted to 88850 shares of Pyxis Oncology, Inc. for $174,364.

Biography of Connealy Pamela Ann

No biography is available at this moment.

2024-11-26PurchasePyxis Oncology, Inc.
PYXS
CFO & COO
88,850
0.1619%
$1.96$174,364-4.52%
2023-09-28PurchasePyxis Oncology, Inc.
PYXS
CFO and COO
8,000
0.0167%
$1.87$14,960+78.43%
2023-09-27PurchasePyxis Oncology, Inc.
PYXS
CFO and COO
6,426
0.0147%
$1.85$11,868+97.55%
2023-09-25PurchasePyxis Oncology, Inc.
PYXS
CFO and COO
12,000
0.0257%
$1.67$20,044+103.93%
2023-09-22PurchasePyxis Oncology, Inc.
PYXS
CFO and COO
5,000
0.0124%
$1.74$8,695+126.88%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.